The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > LATEST
LATEST
-
BUSINESS Shionogi’s OIC Med Naldemedine Accepted for Review in China
June 2, 2025
-
BUSINESS Astellas Nabs Rights to China Firm’s CLDN18.2 ADC
June 2, 2025
-
REGULATORY LDP Group Urges Ministers to Keep Coverage of Pain Relief Patches
June 2, 2025
-
REGULATORY PMDA Reviewing Safety Risks of Thiamazole, Desmopressin
June 2, 2025
-
BUSINESS Daiichi/Merck Pull HER3-DXd Filing for NSCLC in US
June 2, 2025
-
BUSINESS Novo Pairs Up with Sumitomo on Ozempic Promotion in Japan
June 2, 2025
-
REGULATORY Japan Selects JN.1 Substrains for COVID Vaccines in 2025-2026 Season
May 30, 2025
-
REGULATORY Regulatory Reform Panel Calls for Review of Clinical Trial Ad Rules
May 30, 2025
-
BUSINESS Taking on Solid Tumors - 3: J&J to Soon Have 3 Bispecifics in Japan as Rybrevant Gathers Pace
May 30, 2025
-
BUSINESS Shingles Heavily Pitched for GPs as It Enters NIP: Intage April Data
May 30, 2025
-
REGULATORY Ishin Nixes Ruling Bloc’s Draft Social Security Plans over OTC-Like Drug Issue
May 30, 2025
-
BUSINESS Eisai Wins Lenvima Patent Suit in US, Barring Generic to 2036
May 30, 2025
-
BUSINESS Bimzelx Now Available as Single-Injection Option: UCB Japan
May 30, 2025
-
BUSINESS Mitsubishi Re-Files NeuroDerm’s Parkinson’s Drug in US
May 30, 2025
-
BUSINESS Towa, Sawai Log Two-Digit Growth in Operating Profit, but Industry Sees Divide: Tally
May 30, 2025
-
COLUMN Bridging the Talent Gap: Communication Challenges in Japan’s Pharma & Multinationals
May 30, 2025
-
BUSINESS Taking on Solid Tumors - 2: Chugai Poised to Break through Solid Cancer “Wall” with Trispecific Antibodies
May 29, 2025
-
BUSINESS Sawai, Fuso Ordered to Pay 20-Plus Billion Yen in Remitch Patent Suit
May 29, 2025
-
BUSINESS Nothing Decided, Taiyo Says over Media Report on Buyout Proposals
May 29, 2025
-
REGULATORY LDP Pharma Study Group’s Final Proposal Urges Raising of Social Security Budget Ceiling
May 29, 2025
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…